查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2004057

輸尿管鏡設備市場：全球市場預測（按設備類型、技術、配件、應用和最終用戶分類）—2026-2032年

Ureteroscopy Devices Market by Device Type, Technology, Accessories, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，輸尿管鏡設備市場價值將達到 23.1 億美元，到 2026 年將成長至 24.7 億美元，到 2032 年將達到 38 億美元，複合年成長率為 7.33%。

主要市場統計數據
基準年 2025 23.1億美元
預計年份：2026年 24.7億美元
預測年份 2032 38億美元
複合年成長率 (%) 7.33%

本報告從臨床需求、技術進步、採購趨勢以及對策略性相關人員的影響等方面，全面說明了輸尿管鏡設備的演變。

輸尿管鏡設備處於泌尿系統手術創新和微創醫療的交匯點，同時滿足了臨床醫生、醫療系統和患者對提高視野清晰度、降低手術風險和加快術後恢復的需求。對精準治療結石和尿路上皮病變的臨床需求持續推動著人們對光學系統、能量輸送系統以及相關一次性耗材的關注，這些設備旨在最佳化結石取出和腫瘤消融的過程。同時，醫院和門診手術中心不斷變化的優先事項影響著採購週期和設備選擇，而監管和報銷環境則阻礙了設備的普及應用。

正在重塑輸尿管鏡檢查的臨床實踐、技術應用和商業策略的變革性變化。

輸尿管鏡器材的市場格局正經歷多重融合的變革，這些變革正在改變臨床實踐和商業性決策。首先，高解析度數位光學技術的成熟改變了臨床醫師對影像品質和術中決策的預期，使得病灶的表徵更加精細，治療方案也更加可靠。此外，輸尿管鏡與手術室視覺化系統和影像管理系統的深度整合也進一步推動了這項變革，共同提升了輸尿管鏡在複雜診斷和治療流程中的作用。

2025年美國關稅措施對供應鏈建置、採購決策及成本透明度的累積影響。

近期公佈的關稅措施和2025年貿易政策發展趨勢，使得輸尿管鏡設備產業的供應鏈配置對企業而言變得更加關鍵。針對特定醫療設備原料和成品的關稅調整，迫使製造商和經銷商重新評估其採購地點、近岸外包方案和庫存策略，以維持成本競爭力和按時交付的可靠性。為此，各企業正日益關注二級和三級供應商的依賴關係，以識別關稅補貼商品可能受到的影響，並制定風險緩解策略，包括重新談判合約、尋找替代採購管道以及選擇性垂直整合等。

基於細分市場的洞察：將醫療設備類型、臨床應用、終端用戶環境、技術進步和配件生態系統轉化為策略重點。

有效的商業策略始於對細分市場的精準理解。在考慮器械類型時，必須區分軟性輸尿管鏡和半硬性系統。在軟性輸尿管鏡產品系列中，又存在進一步的差異：一是優先考慮高清視覺化的數位軟性平台，二是專注於傳統光纖傳輸架構的光纖軟性平台。這些器械層面的選擇會影響手術範圍、維修和再處理成本以及資金預算分配，每種選擇都需要不同的臨床證據和培訓方法來促進其推廣應用。

區域洞察聚焦在美洲、歐洲、中東和非洲以及亞太地區的採用趨勢和結構差異，以及對打入市場策略。

地理環境對醫療器材的普及和商業性化應用有顯著影響。在美洲，大規模綜合醫療保健系統、眾多私人醫院以及蓬勃發展的門診手術中心網路，共同推動了對高通量一次性產品和功能豐富的可重複使用平台的需求。該地區的醫保報銷機制和資本規劃週期往往側重於臨床效率的顯著提升和可預測的單次手術成本，這影響著醫院和門診環境中對產品的評估方式。此外，該地區為最佳化臨床流程所做的努力以及醫院整合的趨勢，也影響採購規模和標準化機會。

公司層面的洞察，聚焦於產品組合差異化、製造地、智慧財產權趨勢和夥伴關係模式。

輸尿管鏡器材領域的競爭動態取決於各公司如何建構產品系列，涵蓋可重複使用的光學元件、一次性光學元件、能量供應系統和配套配件。領先的創新者優先考慮整合解決方案，這些方案結合了高解析度視覺化、最佳化的雷射相容性和客製化的附件生態系統，以建立高度永續的臨床工作流程。中型公司通常強調針對特定治療領域的價值提案，例如經濟高效的一次性產品或專用籃框和光纖。

為行業領導者提供實用建議，以加速採用、增強韌性，並在臨床和商業途徑中獲取價值。

產業領導者應優先考慮模組化產品組合策略，平衡可重複使用和一次性使用模式。具體而言，應重點關注設定時間、消毒負擔和配件相容性，並根據門診手術中心和醫院的實際運作情況設計產品，這將有助於推動更廣泛的應用。此外，有針對性的臨床證據項目，能夠證明手術效率和以患者為中心的療效，將在與大規模醫療機構和保險公司的談判中發揮關鍵作用。

本報告概述了得出所呈現的研究結果的調查方法，包括數據三角測量、專家參與、檢驗通訊協定和分析框架。

本報告基於多方面的研究方法，結合了對臨床醫生、採購經理和行業高管的專家訪談，以及對監管文件、臨床文獻和醫療設備技術研究途徑的二次研究。主要研究包括結構化訪談，旨在了解醫院和門診環境中的手術流程、醫療設備選擇標準和採購標準。二次分析檢驗了有關臨床模式和技術性能的聲明，重點關注醫療設備的設計特點、配件相容性和已發表的臨床結果。

對於希望根據執行摘要中的見解採取行動的相關人員，本結論整合了策略意義，並概述了下一步的優先步驟。

輸尿管鏡器材市場正處於轉折點，其驅動力來自光學、能量傳輸技術和配件設計的融合，以及採購和醫療服務模式的轉變。這些因素為那些能夠根據醫院和門診手術中心的營運需求調整產品功能，同時兼顧供應鏈韌性和不斷變化的貿易政策風險的公司創造了明確的機會。能否成功推廣應用取決於能否證明其臨床價值、簡化手術流程，以及在不同的醫療環境中實現可預測的營運經濟效益。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：輸尿管鏡設備市場：依設備類型分類

  • 軟性輸尿管鏡
    • 數位軟性
    • 光纖軟性
  • 半硬式輸尿管鏡

第9章：輸尿管鏡設備市場：依技術分類

  • 數位輸尿管鏡
    • 可重複使用的
    • 一次性的
  • 纖維光輸尿管鏡
    • 可重複使用的
    • 一次性的

第10章：輸尿管鏡設備市場：依配件分類

  • 雷射光纖
    • 鈥雷射光纖
    • 铥雷射光纖
  • 石籃
    • 標準籃
    • 沒有傾斜的籃子

第11章 輸尿管鏡設備市場：依應用領域分類

  • 診斷
    • 檢查
    • 視覺化
  • 治療
    • 石材管理
      • 籃式擷取
      • 石頭碎裂
    • 腫瘤管理
      • 切片檢查
      • 雷射消熔

第12章 輸尿管鏡設備市場：依最終用戶分類

  • 門診手術中心
    • 獨立的
    • 醫院附屬機構
  • 醫院

第13章 輸尿管鏡設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 輸尿管鏡設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 輸尿管鏡設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國輸尿管鏡設備市場

第17章：中國輸尿管鏡設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advin Health Care
  • Ambu A/S
  • Boston Scientific Corporation
  • Cliniva Healthcare
  • Coloplast A/S
  • ConMed Corporation
  • Cook Medical LLC
  • Dornier MedTech
  • EMS Electro Medical Systems SA
  • Fujifilm Holdings Corporation
  • KARL STORZ SE & Co. KG
  • LocaMed Limited
  • Maxer Endoscopy GmbH
  • Medtronic plc
  • MicroPort Urocare
  • Olympus Corporation
  • OTU Medical
  • PENTAX Medical
  • Richard Wolf GmbH
  • ROCAMED
  • Stryker Corporation
  • Teleflex Incorporated
  • Vimex Endoscopy
Product Code: MRR-4659C87137F4

The Ureteroscopy Devices Market was valued at USD 2.31 billion in 2025 and is projected to grow to USD 2.47 billion in 2026, with a CAGR of 7.33%, reaching USD 3.80 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.31 billion
Estimated Year [2026] USD 2.47 billion
Forecast Year [2032] USD 3.80 billion
CAGR (%) 7.33%

A comprehensive introduction framing ureteroscopy device evolution across clinical demand, technology progress, procurement dynamics, and implications for strategic stakeholders

Ureteroscopy devices sit at the intersection of urology procedural innovation and minimally invasive care delivery, responding to simultaneous pressures from clinicians, healthcare systems, and patients for improved visualization, reduced procedural risk, and faster recovery. The clinical imperative to manage stone disease and urothelial lesions with precision has driven sustained interest in optics, energy delivery, and ancillary disposables that enhance stone extraction and tumor ablation workflows. Concurrently, evolving hospital and ambulatory surgical center priorities influence procurement cycles and device preference, while regulatory and reimbursement environments shape the speed of adoption.

Technological advances in digital imaging and single-use platforms have catalyzed reconsideration of capital and operating models across care settings. Digital flexible ureteroscopes have elevated image clarity and integration with ancillary imaging systems, while single-use offerings have emerged in response to sterilization complexity, cross-contamination concerns, and throughput constraints. At the same time, developments in laser technology and accessory design-such as baskets and fibers engineered for improved maneuverability and fragmentation efficiency-have narrowed the procedural trade-offs that clinicians weigh during device selection.

In this context, stakeholders must balance clinical efficacy, total procedural cost, and supply resilience. As care pathways decentralize and outpatient settings take on a larger share of urologic procedures, alignment between device design and operating environment becomes a critical determinant of commercial success. The remainder of this summary synthesizes the most consequential shifts, regulatory and trade impacts, segmentation-driven implications, regional nuances, and clear recommendations for leaders seeking to position their portfolios effectively.

Transformative Shifts Reshaping Clinical Practice, Technology Adoption, and Commercial Strategy in Ureteroscopy

The landscape for ureteroscopy devices is undergoing several convergent transformations that are altering clinical practice and commercial calculus. First, the maturation of high-resolution digital optics has changed clinician expectations for image quality and intraoperative decision making, enabling finer lesion characterization and more confident therapeutic maneuvers. This shift is reinforced by better integration with operating room visualization suites and image management systems, which together advance the role of ureteroscopy in complex diagnostic and therapeutic pathways.

Second, the rise of single-use technology is reshaping procurement models and infection control strategies. Facilities increasingly evaluate single-use options not solely on per-procedure cost but on throughput, reprocessing labor, and cross-infection risk mitigation. This has led to hybrid adoption patterns in which reusable and single-use systems coexist, with purchasing decisions driven by procedure volume, sterilization capacity, and clinical preference.

Third, energy delivery and accessory innovation, especially in laser fiber performance and basket design, are shifting the boundary of what can be achieved endoscopically. Improvements in lithotripsy efficiency and tumor ablation precision reduce the need for staged procedures and broaden the patient population eligible for minimally invasive management. These clinical gains translate into shifting procedural mixes across inpatient and ambulatory venues.

Finally, decentralized care delivery and growth in ambulatory surgical centers are prompting manufacturers to refine product portfolios for portability, simplified setup, and rapid turnover. Taken together, these shifts create both opportunity and complexity for product developers and health system partners, demanding coordinated investments in clinical training, evidence generation, and supply chain agility to realize potential gains.

Cumulative Impacts of United States Tariff Actions in 2025 on Supply Chain Structuring, Sourcing Decisions, and Cost Transparency

Recent tariff actions and trade policy signals announced for 2025 have increased the salience of supply chain configuration for companies operating in the ureteroscopy device space. Tariff adjustments applied to certain medical device inputs and finished goods have prompted manufacturers and distributors to reassess sourcing footprints, nearshoring options, and inventory strategies to preserve cost competitiveness and delivery reliability. In response, organizations are increasingly mapping supplier dependencies at the tier-two and tier-three levels to identify latent exposure to tariffed goods and to develop mitigation plans that span contract renegotiation, alternative sourcing, and selective vertical integration.

These policy shifts also influence pricing transparency and contractual negotiation dynamics with health systems and group purchasing organizations. Providers are demanding greater visibility into landed costs and contingency provisions, and procurement cycles now frequently incorporate clauses addressing import duties and supply interruptions. The cumulative effect has been a heightened emphasis on scenario planning and stress-testing commercial models under different trade policy trajectories.

On the manufacturing side, some firms are accelerating localized assembly or qualifying alternate contract manufacturers in non-tariff jurisdictions to reduce duty burden and shorten lead times. Others are redesigning component specifications to minimize the use of tariff-implicated items, while a subset is leveraging tariff mitigation mechanisms where available. Importantly, these responses are not uniform; small and mid-sized companies face different constraints compared with large established firms, which affects competitive dynamics and potential consolidation activity.

Going forward, the interplay between tariff policy and global medical device trade will continue to shape investment choices, strategic partnerships, and the relative attractiveness of reusable versus disposable device models, as duty-sensitive cost components flow through to procurement decisions and clinical adoption patterns.

Segmentation-driven insights translating device type, clinical application, end-user environment, technology pathways, and accessory ecosystems into strategic priorities

An effective commercial strategy begins with precise segment-level understanding. Device type considerations differentiate flexible ureteroscopes from semi-rigid systems; within flexible offerings, a further distinction exists between digital flexible platforms that prioritize high-definition visualization and fiber-optic flexible variants that emphasize traditional light-transmitting architectures. These device-level choices affect procedure scope, repair and reprocessing burdens, and capital budget allotments, and they require distinct clinical evidence and training approaches to drive adoption.

Application-level segmentation separates diagnostic use from therapeutic deployment. Diagnostic applications emphasize inspection and visualization capabilities necessary for lesion detection and mapping, while therapeutic use cases split between stone management and tumor management. Stone management workflows further bifurcate into basket extraction strategies and lithotripsy-centric approaches, each demanding specific accessory compatibility and procedural ergonomics. Tumor management workflows rely on precise biopsy capability and laser ablation performance, which in turn influence device optics, deflection, and energy delivery requirements.

End-user context plays a critical role in adoption patterns. Ambulatory surgical centers, whether freestanding or hospital-affiliated, prioritize throughput efficiency, simplified reprocessing, and predictable per-case operating expenses, whereas hospitals, whether private or public, weigh capital depreciation, breadth of procedural mix, and service-level expectations when selecting devices. These differences drive varied commercial messaging, reimbursement engagement, and deployment models across providers.

Technology segmentation highlights the parallel development of digital and fiber-optic ureteroscopes, each available in reusable and single-use configurations. Strategic choices between reusable and single-use variants hinge on sterilization infrastructure, procedural volume, and long-term cost-of-ownership calculus. Finally, accessory segmentation-such as distinctions between laser fibers and stone baskets and between holmium and thulium fibers or standard and tipless baskets-shapes bundled offering opportunities and aftermarket revenue potential. Aligning product roadmaps to these layered segments enables focused evidence generation, tailored value propositions, and differentiated commercial execution.

Regional insights highlighting adoption dynamics and structural differences across the Americas, Europe Middle East & Africa, and Asia-Pacific with implications for go-to-market strategies

Geographic context materially influences device adoption and commercial execution. In the Americas, large integrated health systems, a strong private hospital presence, and active ambulatory surgical center networks create demand for both high-throughput disposables and feature-rich reusable platforms. Reimbursement structures and capital planning cycles in this region often favor demonstrable clinical efficiency gains and predictable per-procedure costing, which shapes how products are evaluated across hospital and ambulatory settings. Additionally, pathway optimization initiatives and hospital consolidation trends in this region affect purchasing scale and standardization opportunities.

Within Europe, the Middle East & Africa, diversity in reimbursement models, regulatory timelines, and health infrastructure results in differentiated uptake patterns. High-resource markets place a premium on advanced imaging and single-use infection control benefits, while emerging healthcare systems emphasize durable, repairable devices supported by local service networks. Procurement in these markets may also be influenced by national contracting vehicles and regional distributors, necessitating tailored pricing and service propositions.

Asia-Pacific presents a mix of rapid adoption in urban tertiary centers and widening access in regional hospitals and ambulatory facilities. Investments in minimally invasive urology and expanding surgical capacity within the region favor scalable device solutions that balance capital expenditure with per-case economics. Partnerships with local manufacturers and distributors, along with training programs oriented toward procedure standardization, are particularly effective in accelerating adoption across diverse healthcare settings in Asia-Pacific.

Understanding these regional nuances allows manufacturers to prioritize evidence generation, regulatory strategy, and commercial models that align with local procurement behavior, reimbursement priorities, and operational realities.

Company-level insights focusing on portfolio differentiation, manufacturing footprint, intellectual property trends, and partnership models

Competitive dynamics in the ureteroscopy devices space are shaped by how firms configure product portfolios across reusable and disposable optics, energy delivery systems, and complementary accessories. Leading innovators prioritize integrated solutions that combine high-resolution visualization with optimized laser compatibility and bespoke accessory ecosystems to create sticky clinical workflows. Mid-market players frequently emphasize targeted value propositions-such as cost-effective single-use offerings or specialized baskets and fibers-to capture specific procedural niches.

Manufacturing footprint and vertical capability influence competitive positioning. Firms with diversified production and regional assembly capabilities can respond more flexibly to tariff shifts and supply disruptions, while those relying on concentrated manufacturing face different risk profiles. Partnerships with contract manufacturers, strategic alliances for component sourcing, and co-development agreements with clinical opinion leaders help expand product breadth without undermining balance sheets.

Intellectual property and regulatory strategy further differentiate companies. Proprietary imaging software, unique deflection mechanisms, and fiber technologies create barriers to entry and enable premium positioning when accompanied by rigorous clinical validation. At the same time, firms that effectively leverage aftermarket revenue through accessories, consumables, and service agreements strengthen recurring revenue streams and deepen customer relationships.

Finally, go-to-market approaches vary from direct sales models focused on high-touch clinical training and hospital integration to distributor-led strategies that prioritize broader geographic reach. The most successful organizations align their commercial model with the end-user segmentation and regional realities described earlier, investing in clinical evidence, education programs, and service networks that address the practical needs of clinicians and procurement teams.

Actionable recommendations for industry leaders to accelerate adoption, strengthen resilience, and capture value across clinical and commercial pathways

Industry leaders should prioritize modular portfolio strategies that reconcile the coexistence of reusable and single-use modalities. Specifically, aligning product design with the operational realities of ambulatory surgical centers and hospitals-focusing on setup time, sterilization burden, and accessory compatibility-will support wider adoption. In tandem, targeted clinical evidence programs that demonstrate procedural efficiency gains and patient-centered outcomes will be decisive in conversations with high-volume institutions and payers.

Supply chain resilience must be elevated to a strategic priority. Companies should expand multi-sourcing capabilities for critical components, qualify regional assembly partners where feasible, and implement inventory buffering for tariff-sensitive inputs. These actions reduce exposure to trade policy shifts and support predictable delivery performance for key customers.

Commercially, firms should adopt differentiated engagement models that reflect end-user segmentation. High-touch programs emphasizing hands-on training, proctoring, and outcomes tracking work well for tertiary hospitals, while streamlined procurement options and predictable per-case costing resonate with ambulatory surgical centers. Bundled offerings that package scopes, optimized laser fibers, and compatible baskets can simplify purchasing decisions and create measurable total cost of care narratives.

Finally, invest in digital enablement and data capture to quantify procedure-level performance and support value-based conversations with providers. Tele-mentoring, remote diagnostics for device health, and analytics reporting on utilization create additional revenue and service differentiation opportunities while reinforcing clinical trust and long-term partnerships.

Research methodology outlining data triangulation, expert engagement, validation protocols, and analytical frameworks used to derive the insights presented

This synthesis is grounded in a multi-source research approach that integrates primary expert interviews with clinicians, procurement leaders, and industry executives, combined with secondary examination of regulatory filings, clinical literature, and device technical specifications. The primary input included structured interviews designed to capture procedural workflows, device preferences, and procurement criteria across hospital and ambulatory settings. Secondary analysis focused on device design features, accessory compatibility, and published clinical outcomes to validate practice patterns and technology performance claims.

The analysis employed a segmentation-first framework to ensure that insights were relevant to device type, clinical application, end-user environment, technology configuration, and accessory ecosystems. Cross-validation protocols compared interview-based observations against product literature and public regulatory records to confirm claims regarding device capabilities and intended use cases. Sensitivity checks addressed potential bias from single-source testimony by weighting input across multiple clinical and commercial stakeholders.

Interpretation of tariff impacts and supply chain responses combined policy review with supplier-level disclosure and procurement leader perspectives to generate a practical view of likely strategic responses. The regional analysis drew on clinician interviews in representative markets and review of reimbursement and procurement structures to surface realistic adoption constraints and enablers. Together, these methodological elements produced an evidence-informed synthesis designed to support decision makers in commercial planning and product strategy.

Conclusion synthesizing strategic implications and outlining priority next steps for stakeholders seeking to act on the executive summary findings

The ureteroscopy device landscape is at an inflection point defined by converging advances in optics, energy delivery, and accessory design coupled with shifting procurement and care delivery models. These forces create distinct opportunities for firms that can align product functionality with the operational needs of hospitals and ambulatory surgical centers, while simultaneously addressing supply chain resilience and evolving trade policy risk. Adoption choices will hinge on the ability to demonstrate clinical value, simplify procedural workflows, and deliver predictable operating economics for diverse care settings.

Priority next steps for stakeholders include clarifying segment-specific value propositions, accelerating targeted clinical evidence that maps to end-user priorities, and strengthening manufacturing and sourcing flexibility to respond to tariff and logistics disruptions. Organizations should also refine commercial approaches to reflect regional reimbursement realities and to adapt messaging for distinct buyer types across private hospitals, public hospitals, freestanding ambulatory facilities, and hospital-affiliated outpatient centers.

By focusing on these strategic imperatives, companies and provider partners can better navigate the evolving landscape, capture opportunities presented by technological innovation, and deliver improved outcomes for patients undergoing diagnostic and therapeutic ureteroscopic procedures. The remainder of the report offers the detailed appendices and evidence base required to operationalize these conclusions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ureteroscopy Devices Market, by Device Type

  • 8.1. Flexible Ureteroscopes
    • 8.1.1. Digital Flexible
    • 8.1.2. Fiber-Optic Flexible
  • 8.2. Semi-Rigid Ureteroscopes

9. Ureteroscopy Devices Market, by Technology

  • 9.1. Digital Ureteroscopes
    • 9.1.1. Reusable
    • 9.1.2. Single Use
  • 9.2. Fiber-Optic Ureteroscopes
    • 9.2.1. Reusable
    • 9.2.2. Single Use

10. Ureteroscopy Devices Market, by Accessories

  • 10.1. Laser Fibers
    • 10.1.1. Holmium Laser Fibers
    • 10.1.2. Thulium Laser Fibers
  • 10.2. Stone Baskets
    • 10.2.1. Standard Baskets
    • 10.2.2. Tipless Baskets

11. Ureteroscopy Devices Market, by Application

  • 11.1. Diagnostic
    • 11.1.1. Inspection
    • 11.1.2. Visualization
  • 11.2. Therapeutic
    • 11.2.1. Stone Management
      • 11.2.1.1. Basket Extraction
      • 11.2.1.2. Lithotripsy
    • 11.2.2. Tumor Management
      • 11.2.2.1. Biopsy
      • 11.2.2.2. Laser Ablation

12. Ureteroscopy Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
    • 12.1.1. Freestanding
    • 12.1.2. Hospital Affiliated
  • 12.2. Hospitals

13. Ureteroscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ureteroscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ureteroscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Ureteroscopy Devices Market

17. China Ureteroscopy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Advin Health Care
  • 18.6. Ambu A/S
  • 18.7. Boston Scientific Corporation
  • 18.8. Cliniva Healthcare
  • 18.9. Coloplast A/S
  • 18.10. ConMed Corporation
  • 18.11. Cook Medical LLC
  • 18.12. Dornier MedTech
  • 18.13. EMS Electro Medical Systems S.A.
  • 18.14. Fujifilm Holdings Corporation
  • 18.15. KARL STORZ SE & Co. KG
  • 18.16. LocaMed Limited
  • 18.17. Maxer Endoscopy GmbH
  • 18.18. Medtronic plc
  • 18.19. MicroPort Urocare
  • 18.20. Olympus Corporation
  • 18.21. OTU Medical
  • 18.22. PENTAX Medical
  • 18.23. Richard Wolf GmbH
  • 18.24. ROCAMED
  • 18.25. Stryker Corporation
  • 18.26. Teleflex Incorporated
  • 18.27. Vimex Endoscopy

LIST OF FIGURES

  • FIGURE 1. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL URETEROSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL URETEROSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES URETEROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA URETEROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 253. GCC URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. GCC URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. GCC URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 256. GCC URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. GCC URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 258. GCC URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 259. GCC URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 260. GCC URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 261. GCC URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 262. GCC URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. GCC URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 264. GCC URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 265. GCC URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 266. GCC URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 267. GCC URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. GCC URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 301. G7 URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. G7 URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. G7 URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 304. G7 URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 305. G7 URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 306. G7 URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 307. G7 URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 308. G7 URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 309. G7 URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 310. G7 URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. G7 URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 312. G7 URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 313. G7 URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 314. G7 URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 315. G7 URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. G7 URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 318. NATO URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. NATO URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 320. NATO URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. NATO URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 322. NATO URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 323. NATO URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 324. NATO URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 325. NATO URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 326. NATO URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLI